Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20305-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20305-1-AP, RRID:AB_10732838
- Product name
- CD47 antibody
- Antibody type
- Polyclonal
- Description
- CD47 antibody (Cat. #20305-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis.
CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles.
Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.
Aptamer-Based Erythrocyte-Derived Mimic Vesicles Loaded with siRNA and Doxorubicin for the Targeted Treatment of Multidrug-Resistant Tumors.
Zhao Q, Cai Q, Yu S, Ji J, Zhu Z, Yan C, Zhang J
Frontiers in cell and developmental biology 2021;9:745120
Frontiers in cell and developmental biology 2021;9:745120
CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles.
Kaur S, Saldana AC, Elkahloun AG, Petersen JD, Arakelyan A, Singh SP, Jenkins LM, Kuo B, Reginauld B, Jordan DG, Tran AD, Wu W, Zimmerberg J, Margolis L, Roberts DD
Journal of cell communication and signaling 2021 Nov 29;
Journal of cell communication and signaling 2021 Nov 29;
Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
Fu F, Zhang Y, Gao Z, Zhao Y, Wen Z, Han H, Li Y, Hu H, Chen H
Journal of cancer research and clinical oncology 2021 Mar;147(3):739-747
Journal of cancer research and clinical oncology 2021 Mar;147(3):739-747
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.
Kaur S, Schwartz AL, Jordan DG, Soto-Pantoja DR, Kuo B, Elkahloun AG, Mathews Griner L, Thomas CJ, Ferrer M, Thomas A, Tang SW, Rajapakse VN, Pommier Y, Roberts DD
Frontiers in oncology 2019;9:994
Frontiers in oncology 2019;9:994
Aptamer-Based Erythrocyte-Derived Mimic Vesicles Loaded with siRNA and Doxorubicin for the Targeted Treatment of Multidrug-Resistant Tumors.
Wang T, Luo Y, Lv H, Wang J, Zhang Y, Pei R
ACS applied materials & interfaces 2019 Dec 11;11(49):45455-45466
ACS applied materials & interfaces 2019 Dec 11;11(49):45455-45466
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CD47 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human CD47. This antibody recognizes human antigen. The CD47 antibody has been validated for the following applications: ELISA, WB analysis.
